Experts weigh in on spot XRP ETF in US; AI altcoin presale hits major milestone
![Experts weigh in on spot XRP ETF in US; AI altcoin presale hits major milestone](https://crypto.news/app/uploads/2023/06/InQubeta-QUBE08.jpg)
Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only.
This article discusses the possibility of an XRP exchange-traded fund (ETF) being introduced in the United States. Additionally, it looks into InQubeta (QUBE), a defi project that recently hit a key milestone.
Will XRP ETF debut in the U.S.?
The cryptocurrency community is discussing the possibility of an XRP exchange-traded fund (ETF) being launched in the U.S.
However, Ripple’s legal battle with the U.S. SEC has complicated the situation, and some analysts believe it may be difficult for a spot XRP ETF to launch.Â
Nonetheless, experts suggest that an XRP ETF may be possible in 2025 if the crypto achieves regulatory clarity.
InQubeta’s presale hits major milestone
InQubeta has raised over $8.6 million in its presale.
The project aims to democratize investment by allowing anyone to participate in the AI revolution through its decentralized investment platform.
InQubeta offers a unique investment ecosystem where AI startups raise capital by selling NFTs representing investment opportunities.Â
These tokens become valuable assets as the startups grow, and investors can purchase them like stocks in traditional markets.
InQubeta also allows investors to resell their NFTs and provides a direct investment avenue through its native ERC-20 token, QUBE.
Since the platform aims to foster innovation in crypto while addressing significant issues in the altcoin space, analysts expect more growth.
Conclusion
Investors looking to explore opportunities in the crypto space may consider checking out InQubeta, which has gained popularity due to its features and presale success, raising over $8.6 million.Â
Disclosure: This content is provided by a third party. crypto.news does not endorse any product mentioned on this page. Users must do their own research before taking any actions related to the company.